Earn CME: https://www.naccme.com/program/19-lm-03 In this webcast from the ‘Minimal Residual Disease in Hematologic Malignancies Testing Considerations and Challenges’ symposium during the 2019 Lymphoma & Myeloma conference in New York, Dr. Raphael Fonseca discusses use the of MRD testing, single cell RNA sequencing, and cell free DNA testing in the treatment of hematologic malignancies. © 2019 Imedex, an HMP Company
MRD Detection, Single Cell RNA Seq., Cell Free DNA, etc: Does it Impact Treatment?
